FindTrial
Sign In

A multi-centre, phase II - III randomised clinical trial and observational study of defibrotide for the treatment of hepatic veno-occlusive disease after stem cell transplant

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN65464501
Enrollment
Unknown
Registered
2003-09-12
Start date
2003-02-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatic veno-occlusive disease (VOD) Digestive System Other diseases of liver

Interventions

Randomised phase II - III multi-centre study of defibrotide in hepatic veno-occlusive disease after stem cell transplant.

Sponsors

Record provided by the NHS Trusts Clinical Trials Register - Department of Health (UK)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All patients with diagnosis of VOD after a stem cell transplant.

Exclusion criteria

Exclusion criteria: Not provided at time of registration

Design outcomes

Primary

MeasureTime frame
Survival at 7, 14, 30, 60 and 100 days after diagnosis.—

Secondary

MeasureTime frame
Not provided at time of registration—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026